Véronique Bougie

Chief Operating Officer at SemaThera Inc - Westmount, QC, CA

Véronique Bougie's Colleagues at SemaThera Inc
Francois Binet

Senior Principal Scientist

Contact Francois Binet

Garth Cumberlidge

President, Director & Chief Executive Officer

Contact Garth Cumberlidge

Véronique Bougie's Contact Details
HQ
N/A
Location
Montreal, Quebec, Canada
Company
SemaThera Inc
Véronique Bougie's Company Details
SemaThera Inc logo, SemaThera Inc contact details

SemaThera Inc

Westmount, QC, CA • 5 - 9 Employees
BioTech/Drugs

SemaThera is a spin-off company from AmorChem Fund 1, which focuses on a novel target, semaphorin 3A (SEMA3A). The Company is currently developing bispecific SEMA3A / VEGF inhibitors (traps) to prevent vascular leakage and damper the inflammation in diabetic macular edema (DME). The technology targets the 30% DME patients who are poor responders to current anti-VEGF therapies.

diabetic macular edema ocular diseases semaphorin 3A
Details about SemaThera Inc
Frequently Asked Questions about Véronique Bougie
Véronique Bougie currently works for SemaThera Inc.
Véronique Bougie's role at SemaThera Inc is Chief Operating Officer.
Véronique Bougie's email address is ***@semathera.com. To view Véronique Bougie's full email address, please signup to ConnectPlex.
Véronique Bougie works in the BioTech/Drugs industry.
Véronique Bougie's colleagues at SemaThera Inc are Francois Binet, Normand Beaulieu, Garth Cumberlidge, Michelle Barbagallo and others.
Véronique Bougie's phone number is N/A
See more information about Véronique Bougie